ERP source tracking and localization from single trial EEG MEG signals

Electroencephalography (EEG) and magnetoencephalography (MEG), which are two of a number of neuroimaging techniques, are scalp recordings of the electrical activity of the brain. EEG and MEG (E/MEG) have excellent temporal resolution, they are easy to acquire, and have a wide range of applications in science, medicine and engineering. These valuable signals, however, suffer from poor spatial resolution and in many cases from very low signal to noise ratios. In this study, new computational methods for analyzing and improving the quality of E/MEG signals are presented. We mainly focus on single trial event-related potential (ERP) estimation and E/MEG dipole source localization. Several methods basically based on particle filtering (PF) are proposed. First, a method using PF for single trial estimation of ERP signals is considered. In this method, the wavelet coefficients of each ERP are assumed to be a Markovian process and do not change extensively across trials. The wavelet coefficients are then estimated recursively using PF. The results both for simulations and real data are compared with those of the well known Kalman Filtering (KF) approach. In the next method we move from single trial estimation to source localization of E/MEG signals. The beamforming (BF) approach for dipole source localization is generalized based on prior information about the noise. BF is in fact a spatial filter that minimizes the power of all the signals at the output of the filter except those that come from the locations of interest. In the proposed method, using two more constraints than in the classical BF formulation, the output noise powers are minimized and the interference activities are stopped.EThOS - Electronic Theses Online ServiceGBUnited Kingdo

ERP source tracking and localization from single trial EEG MEG signals

Electroencephalography (EEG) and magnetoencephalography (MEG), which are two of a number of neuroimaging techniques, are scalp recordings of the electrical activity of the brain. EEG and MEG (E/MEG) have excellent temporal resolution, they are easy to acquire, and have a wide range of applications in science, medicine and engineering. These valuable signals, however, suffer from poor spatial resolution and in many cases from very low signal to noise ratios. In this study, new computational methods for analyzing and improving the quality of E/MEG signals are presented. We mainly focus on single trial event-related potential (ERP) estimation and E/MEG dipole source localization. Several methods basically based on particle filtering (PF) are proposed. First, a method using PF for single trial estimation of ERP signals is considered. In this method, the wavelet coefficients of each ERP are assumed to be a Markovian process and do not change extensively across trials. The wavelet coefficients are then estimated recursively using PF. The results both for simulations and real data are compared with those of the well known Kalman Filtering (KF) approach. In the next method we move from single trial estimation to source localization of E/MEG signals. The beamforming (BF) approach for dipole source localization is generalized based on prior information about the noise. BF is in fact a spatial filter that minimizes the power of all the signals at the output of the filter except those that come from the locations of interest. In the proposed method, using two more constraints than in the classical BF formulation, the output noise powers are minimized and the interference activities are stopped

A novel semiblind signal extraction approach for the removal of eye-blink artifact from EEGs

A novel blind signal extraction (BSE) scheme for the removal of eye-blink artifact from electroencephalogram (EEG) signals is proposed. In this method, in order to remove the artifact, the source extraction algorithm is provided with an estimation of the column of the mixing matrix corresponding to the point source eye-blink artifact. The eye-blink source is first extracted and then cleaned, artifact-removed EEGs are subsequently reconstructed by a deflation method. The a priori knowledge, namely, the vector, corresponding to the spatial distribution of the eye-blink factor, is identified by fitting a space-time-frequency (STF) model to the EEG measurements using the parallel factor (PARAFAC) analysis method. Hence, we call the BSE approach semiblind signal extraction (SBSE). This approach introduces the possibility of incorporating PARAFAC within the blind source extraction framework for single trial EEG processing applications and the respected formulations. Moreover, aiming at extracting the eyeblink artifact, it exploits the spatial as well as temporal prior information during the extraction procedure. Experiments on synthetic data and real EEG measurements confirm that the proposed algorithm effectively identifies and removes the eye-blink artifact from raw EEG measurements

MEG Can Map Short and Long-Term Changes in Brain Activity following Deep Brain Stimulation for Chronic Pain

Deep brain stimulation (DBS) has been shown to be clinically effective for some forms of treatment-resistant chronic pain, but the precise mechanisms of action are not well understood. Here, we present an analysis of magnetoencephalography (MEG) data from a patient with whole-body chronic pain, in order to investigate changes in neural activity induced by DBS for pain relief over both short- and long-term. This patient is one of the few cases treated using DBS of the anterior cingulate cortex (ACC). We demonstrate that a novel method, null-beamforming, can be used to localise accurately brain activity despite the artefacts caused by the presence of DBS electrodes and stimulus pulses. The accuracy of our source localisation was verified by correlating the predicted DBS electrode positions with their actual positions. Using this beamforming method, we examined changes in whole-brain activity comparing pain relief achieved with deep brain stimulation (DBS ON) and compared with pain experienced with no stimulation (DBS OFF). We found significant changes in activity in pain-related regions including the pre-supplementary motor area, brainstem (periaqueductal gray) and dissociable parts of caudal and rostral ACC. In particular, when the patient reported experiencing pain, there was increased activity in different regions of ACC compared to when he experienced pain relief. We were also able to demonstrate long-term functional brain changes as a result of continuous DBS over one year, leading to specific changes in the activity in dissociable regions of caudal and rostral ACC. These results broaden our understanding of the underlying mechanisms of DBS in the human brain

ERG finally has something to YAP about in prostate cancer

SummaryThe significance of ERG in human prostate cancer is unclear because mouse prostate is resistant to ERG-mediated transformation. We determined that ERG activates the transcriptional program regulated by YAP1 of the Hippo signaling pathway and found that prostate-specific activation of either ERG or YAP1 in mice induces similar transcriptional changes and results in age-related prostate tumors. ERG binds to chromatin regions occupied by TEAD/YAP1 and transactivates Hippo target genes. In addition, in human luminal-type prostate cancer cells, ERG binds to the promoter of YAP1 and is necessary for YAP1 expression. These results provide direct genetic evidence of a causal role for ERG in prostate cancer and reveal a connection between ERG and the Hippo signaling pathway

Estimating global injuries morbidity and mortality : methods and data used in the Global Burden of Disease 2017 study

Background: While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria. Methods: In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation. In summary, these methods included estimating cause-specific mortality for every cause of injury, and then estimating incidence for every cause of injury. Non-fatal disability for each cause is then calculated based on the probabilities of suffering from different types of bodily injury experienced. Results: GBD 2017 produced morbidity and mortality estimates for 38 causes of injury. Estimates were produced in terms of incidence, prevalence, years lived with disability, cause-specific mortality, years of life lost and disability-adjusted life-years for a 28-year period for 22 age groups, 195 countries and both sexes. Conclusions: GBD 2017 demonstrated a complex and sophisticated series of analytical steps using the largest known database of morbidity and mortality data on injuries. GBD 2017 results should be used to help inform injury prevention policy making and resource allocation. We also identify important avenues for improving injury burden estimation in the future

Estimating global injuries morbidity and mortality : methods and data used in the Global Burden of Disease 2017 study

Background While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria. Methods In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation. In summary, these methods included estimating cause-specific mortality for every cause of injury, and then estimating incidence for every cause of injury. Non-fatal disability for each cause is then calculated based on the probabilities of suffering from different types of bodily injury experienced. Results GBD 2017 produced morbidity and mortality estimates for 38 causes of injury. Estimates were produced in terms of incidence, prevalence, years lived with disability, cause-specific mortality, years of life lost and disability-adjusted life-years for a 28-year period for 22 age groups, 195 countries and both sexes. Conclusions GBD 2017 demonstrated a complex and sophisticated series of analytical steps using the largest known database of morbidity and mortality data on injuries. GBD 2017 results should be used to help inform injury prevention policy making and resource allocation. We also identify important avenues for improving injury burden estimation in the future.Peer reviewe

Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019 : a comprehensive demographic analysis for the Global Burden of Disease Study 2019

Background: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected subnational locations from 1950 to 2019. Methods: 8078 country-years of vital registration and sample registration data, 938 surveys, 349 censuses, and 238 other sources were identified and used to estimate age-specific fertility. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate age-specific fertility rates for 5-year age groups between ages 15 and 49 years. With extensions to age groups 10–14 and 50–54 years, the total fertility rate (TFR) was then aggregated using the estimated age-specific fertility between ages 10 and 54 years. 7417 sources were used for under-5 mortality estimation and 7355 for adult mortality. ST-GPR was used to synthesise data sources after correction for known biases. Adult mortality was measured as the probability of death between ages 15 and 60 years based on vital registration, sample registration, and sibling histories, and was also estimated using ST-GPR. HIV-free life tables were then estimated using estimates of under-5 and adult mortality rates using a relational model life table system created for GBD, which closely tracks observed age-specific mortality rates from complete vital registration when available. Independent estimates of HIV-specific mortality generated by an epidemiological analysis of HIV prevalence surveys and antenatal clinic serosurveillance and other sources were incorporated into the estimates in countries with large epidemics. Annual and single-year age estimates of net migration and population for each country and territory were generated using a Bayesian hierarchical cohort component model that analysed estimated age-specific fertility and mortality rates along with 1250 censuses and 747 population registry years. We classified location-years into seven categories on the basis of the natural rate of increase in population (calculated by subtracting the crude death rate from the crude birth rate) and the net migration rate. We computed healthy life expectancy (HALE) using years lived with disability (YLDs) per capita, life tables, and standard demographic methods. Uncertainty was propagated throughout the demographic estimation process, including fertility, mortality, and population, with 1000 draw-level estimates produced for each metric. Findings: The global TFR decreased from 2·72 (95% uncertainty interval [UI] 2·66–2·79) in 2000 to 2·31 (2·17–2·46) in 2019. Global annual livebirths increased from 134·5 million (131·5–137·8) in 2000 to a peak of 139·6 million (133·0–146·9) in 2016. Global livebirths then declined to 135·3 million (127·2–144·1) in 2019. Of the 204 countries and territories included in this study, in 2019, 102 had a TFR lower than 2·1, which is considered a good approximation of replacement-level fertility. All countries in sub-Saharan Africa had TFRs above replacement level in 2019 and accounted for 27·1% (95% UI 26·4–27·8) of global livebirths. Global life expectancy at birth increased from 67·2 years (95% UI 66·8–67·6) in 2000 to 73·5 years (72·8–74·3) in 2019. The total number of deaths increased from 50·7 million (49·5–51·9) in 2000 to 56·5 million (53·7–59·2) in 2019. Under-5 deaths declined from 9·6 million (9·1–10·3) in 2000 to 5·0 million (4·3–6·0) in 2019. Global population increased by 25·7%, from 6·2 billion (6·0–6·3) in 2000 to 7·7 billion (7·5–8·0) in 2019. In 2019, 34 countries had negative natural rates of increase; in 17 of these, the population declined because immigration was not sufficient to counteract the negative rate of decline. Globally, HALE increased from 58·6 years (56·1–60·8) in 2000 to 63·5 years (60·8–66·1) in 2019. HALE increased in 202 of 204 countries and territories between 2000 and 2019